Ervebo

The rVSV-ZEBOV vaccine is an Ebola vaccine for adults that prevents Ebola caused by the Zaire ebolavirus. The vaccine was approved for medical use in the European Union and the United States in 2019 and has been used extensively in outbreaks in the Democratic Republic of the Congo, with over 90,000 people vaccinated. When used in ring vaccination, the vaccine has shown a high level of protection, with a 97.5% effectiveness at stopping Ebola transmission. The vaccine has mild to moderate adverse effects, including headache, fatigue, and muscle pain, and has been used in several outbreaks since 2016.learn more on wikipedia